Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002021233-26-000002
Filing Date
2026-01-29
Accepted
2026-01-29 16:30:09
Documents
1
Period of Report
2026-01-27

Document Format Files

Seq Description Document Type Size
1 form4-01292026_040101.html 4  
1 form4-01292026_040101.xml 4 3907
  Complete submission text file 0002021233-26-000002.txt   5438
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-839-4360
MapLight Therapeutics, Inc. (Issuer) CIK: 0001770069 (see all company filings)

EIN.: 832163243 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MAPLIGHT THERAPEUTICS, INC. 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address
Foff Erin Pennock (Reporting) CIK: 0002021233 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42914 | Film No.: 26578510